New delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: the Minipellet.
Ochiya
T
T
National Cancer Center Research Institute, Tokyo, Japan.
Takahama
Y
Y
Nagahara
S
S
Sumita
Y
Y
Hisada
A
A
Itoh
H
H
Nagai
Y
Y
Terada
M
M
D000818:Animals; D003094:Collagen / Q000008:administration & dosage / Q000737:chemistry; D004247:DNA / Q000737:chemistry; D003692:Delayed-Action Preparations; D004337:Drug Carriers / Q000008:administration & dosage / Q000737:chemistry; D016503:Drug Delivery Systems; D005260:Female; D051519:Fibroblast Growth Factor 4; D005346:Fibroblast Growth Factors / Q000008:administration & dosage* / Q000032:analysis / Q000235:genetics / Q000378:metabolism / Q000494:pharmacology; D051379:Mice; D008813:Mice, Inbred ICR; D018482:Muscle, Skeletal / Q000378:metabolism; D010957:Plasmids / Q000008:administration & dosage* / Q000378:metabolism / Q000493:pharmacokinetics; D011518:Proto-Oncogene Proteins / Q000008:administration & dosage* / Q000032:analysis / Q000235:genetics / Q000378:metabolism / Q000494:pharmacology; D011994:Recombinant Proteins / Q000235:genetics / Q000378:metabolism / Q000494:pharmacology
D003692:Delayed-Action Preparations; D004337:Drug Carriers; C496446:Fgf4 protein, mouse; D051519:Fibroblast Growth Factor 4; D011518:Proto-Oncogene Proteins; D011994:Recombinant Proteins; C059821:atelocollagen; D005346:Fibroblast Growth Factors; D003094:Collagen; D004247:DNA